KRYSTAL-1: Updated activity and safety of adagrasib (MRTX849) in patients with unresectable or metastatic pancreatic cancer and other gastrointestinal tumors harboring a KRASG12C mutation - Bekaii-Saab, TS; Spira, AI; Yaeger, R (J Clin Oncol, 2022)
et al.